Intelligent Bio Solutions Inc. (INBS) SEC filings

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value

$1.76−0.17 (-8.81%)

Close on Nov 13, 2026Market cap $5.33MP/E –Yield –

SEC filings

40 of Intelligent Bio Solutions's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 10, 2026	Nov 10, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2026	Nov 10, 2026	SEC EDGAR
Proxy statement	DEF 14A	Nov 2, 2026	Nov 2, 2026	SEC EDGAR
Annual report, amended	10-K/A	Jun 30, 2026	Oct 21, 2026	SEC EDGAR
Current report	8-K	Oct 12, 2026	Oct 13, 2026	SEC EDGAR
Current report	8-K	Sep 10, 2026	Sep 11, 2026	SEC EDGAR
Current report	8-K	Sep 9, 2026	Sep 9, 2026	SEC EDGAR
Current report	8-K	Aug 31, 2026	Sep 2, 2026	SEC EDGAR
Current report	8-K	Sep 1, 2026	Sep 1, 2026	SEC EDGAR
Current report	8-K	Aug 28, 2026	Aug 28, 2026	SEC EDGAR
Current report	8-K	Aug 19, 2026	Aug 19, 2026	SEC EDGAR
Annual report	10-K	Jun 30, 2026	Aug 19, 2026	SEC EDGAR
Current report	8-K	Aug 11, 2026	Aug 11, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Aug 3, 2026	Aug 3, 2026	SEC EDGAR
Current report	8-K	Jul 31, 2026	Aug 3, 2026	SEC EDGAR
Current report	8-K	Jul 23, 2026	Jul 23, 2026	SEC EDGAR
Current report	8-K	Jul 21, 2026	Jul 21, 2026	SEC EDGAR
Current report	8-K	Jun 16, 2026	Jun 16, 2026	SEC EDGAR
Current report	8-K	Jun 2, 2026	Jun 2, 2026	SEC EDGAR
Current report	8-K	May 13, 2026	May 14, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 13, 2026	SEC EDGAR
Current report	8-K	Apr 20, 2026	Apr 20, 2026	SEC EDGAR
Current report	8-K	Mar 18, 2026	Mar 23, 2026	SEC EDGAR
Current report	8-K	Feb 25, 2026	Feb 25, 2026	SEC EDGAR
Current report	8-K	Feb 12, 2026	Feb 12, 2026	SEC EDGAR
Quarterly report	10-Q	Dec 31, 2025	Feb 12, 2026	SEC EDGAR
Current report	8-K	Feb 5, 2026	Feb 5, 2026	SEC EDGAR
Current report	8-K	Jan 28, 2026	Jan 28, 2026	SEC EDGAR
Current report	8-K	Jan 7, 2026	Jan 8, 2026	SEC EDGAR
Current report	8-K	Dec 31, 2025	Jan 2, 2026	SEC EDGAR
Current report	8-K	Dec 31, 2025	Dec 31, 2025	SEC EDGAR
Current report	8-K	Dec 15, 2025	Dec 16, 2025	SEC EDGAR
Current report	8-K	Dec 12, 2025	Dec 12, 2025	SEC EDGAR
Current report	8-K	Dec 2, 2025	Dec 2, 2025	SEC EDGAR
Current report	8-K	Nov 25, 2025	Nov 28, 2025	SEC EDGAR
Current report	8-K	Nov 12, 2025	Nov 12, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 12, 2025	SEC EDGAR
Current report	8-K	Nov 4, 2025	Nov 7, 2025	SEC EDGAR
Current report	8-K	Oct 30, 2025	Oct 30, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Intelligent Bio Solutions's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Dec 16, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is INBS.

Compare: INBS vs LUCD · INBS vs FEMY · INBS vs ICCM · INBS vs SINT · INBS vs ECIA

Revenue growth36.5% · median 10.3%

Gross margin50.9% · median 56.1%

Operating margin-272.2% · median -616.6%

Net margin-269.3% · median -448.3%

Company	Revenue	Growth
ECIA	$6.30M	-3.0%
LUCD	$5.44M	+23.6%
INBS	$4.50M	+36.5%
SINT	$3.31M	+160.8%
FEMY	$1.97M	-4.2%
ICCM	–	–

Company

Next earnings (est.): Feb 11, 2027, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: June 30
Employees: 14
Held by institutions: 6.0%
Auditor: UHY LLP
SEC CIK: 1725430

Advertisement
300 × 250

See a number that looks wrong?